- Continuing the prescription drug monitoring program (program) until September 1, 2028 ( sections 4 and 5 of the bill);
- Authorizing the state board of pharmacy (board) to promulgate rules that identify a list of prescription drugs that are not currently listed as controlled substances and require such drugs to be tracked through the program ( section 2 );
- Authorizing each coroner to authorize deputy coroners to access the program ( section 2 );
- Authorizing the board to create a data retention schedule for information obtained and stored by the program ( section 2 );
- Requiring the board to report its efforts to seek outside funding for the program during the "State Measurement for Accountable, Responsive, and Transparent (SMART) Government Act" hearings ( section 3 ); and
- Making a technical change to remove a reference to the department of health care policy and financing from the statute as that department does not have access to the program ( section 2 ).
(Note: This summary applies to this bill as introduced.)